Alembic has a cumulative total of 219 ANDA approvals (192 final approvals and 27 tentative approvals) from the USFDA ...

Alembic Pharmaceuticals announced that it has received Tentative Approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Olopatadine Hydrochloride ...

Olopatadine HCl 0.1%; oph soln; contains benzalkonium chloride. <2yrs: consult physician. ≥2yrs: 1 drop in the affected eye(s) twice daily every 6–8hrs; max: twice per day. Eye pain, changes ...

Olopatadine HCl 0.2%; oph soln; contains benzalkonium chloride. Eye pain, changes in vision, increased redness of the eye, itching worsens or lasts for >72hrs; discontinue and evaluate if develops.

Alembic Pharma secures USFDA nod for generic heart failure medication Alembic Pharmaceuticals reported a 25% increase in ...

If you are using the over-the-counter product to self-treat, read and follow all directions on the product package before using this medication. If you have any questions, consult your pharmacist ...

Alembic has a cumulative total of 219 ANDA approvals (192 final approvals and 27 tentative approvals) from USFDA.

If you are using the over-the-counter product to self-treat, read and follow all directions on the product package before using this medication. If you have any questions, consult your pharmacist ...

Review the side-effects of Olopatadine as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of ...

Get detailed information on Olopatadine, including pronunciation, uses, dosage guidelines, indications, and instructions on how and when to take it and when to avoid it. The updated prescription ...